HK1032404A1 - 2,4,4-Trisubstituted-1,3-dioxolane antifungals. - Google Patents

2,4,4-Trisubstituted-1,3-dioxolane antifungals.

Info

Publication number
HK1032404A1
HK1032404A1 HK01103123A HK01103123A HK1032404A1 HK 1032404 A1 HK1032404 A1 HK 1032404A1 HK 01103123 A HK01103123 A HK 01103123A HK 01103123 A HK01103123 A HK 01103123A HK 1032404 A1 HK1032404 A1 HK 1032404A1
Authority
HK
Hong Kong
Prior art keywords
aryl
6alkyl
hydrogen
independently
optionally substituted
Prior art date
Application number
HK01103123A
Other languages
English (en)
Inventor
Lieven Meerpoel
Jan Heeres
Bossche Hugo Florent A Vanden
Der Veken Louis Jozef Elis Van
Frank Christopher Odds
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1032404A1 publication Critical patent/HK1032404A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
HK01103123A 1997-07-11 2001-05-03 2,4,4-Trisubstituted-1,3-dioxolane antifungals. HK1032404A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97202181 1997-07-11
PCT/EP1998/004194 WO1999002523A1 (en) 1997-07-11 1998-07-07 2,4,4-trisubstituted-1,3-dioxolane antifungals

Publications (1)

Publication Number Publication Date
HK1032404A1 true HK1032404A1 (en) 2001-07-20

Family

ID=8228553

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01103123A HK1032404A1 (en) 1997-07-11 2001-05-03 2,4,4-Trisubstituted-1,3-dioxolane antifungals.

Country Status (34)

Country Link
US (1) US6387906B1 (es)
EP (1) EP1068200B1 (es)
KR (1) KR100540460B1 (es)
AP (1) AP1379A (es)
AR (1) AR015130A1 (es)
AT (1) ATE289303T1 (es)
AU (1) AU749760B2 (es)
BG (1) BG64314B1 (es)
BR (1) BRPI9811679B8 (es)
CA (1) CA2295090C (es)
CZ (1) CZ297453B6 (es)
DE (1) DE69829082T2 (es)
DK (1) DK1068200T3 (es)
EA (1) EA002828B1 (es)
EE (1) EE04155B1 (es)
ES (1) ES2238765T3 (es)
GE (1) GEP20033054B (es)
HK (1) HK1032404A1 (es)
HR (1) HRP20000007B1 (es)
HU (1) HU225159B1 (es)
ID (1) ID23783A (es)
IL (1) IL133919A (es)
MY (1) MY118844A (es)
NO (1) NO318328B1 (es)
NZ (1) NZ501982A (es)
PL (1) PL193703B1 (es)
PT (1) PT1068200E (es)
SI (1) SI1068200T1 (es)
SK (1) SK285321B6 (es)
TR (1) TR200000154T2 (es)
TW (1) TW593312B (es)
UA (1) UA71543C2 (es)
WO (1) WO1999002523A1 (es)
ZA (1) ZA986160B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19945982A1 (de) * 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
US20040086567A1 (en) * 2002-10-30 2004-05-06 Pawan Seth Bioequivalent composition of itraconazole and a hydrophilic polymer
AU2009223833A1 (en) * 2008-03-03 2009-09-17 Stiefel Laboratories, Inc. Processes for preparing enantiomerically pure diol and dioxolane compounds
WO2010099518A2 (en) * 2009-02-27 2010-09-02 Thesis Chemistry, Llc Method for manufacture of 2-oxoimidazolidines
CN105777486B (zh) * 2016-03-30 2018-09-11 浙江大学宁波理工学院 一种2-[2-(2,4-二氟苯基)-2-丙烯-1-基]-1,3-丙二醇的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4619931A (en) * 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
CA1292472C (en) 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
US4788190A (en) * 1986-12-24 1988-11-29 Schering Corporation 2,4,4-tri- and 2,2,4,4-tetra substituted-1,3-dioxolane antifungal, antiallergy compounds
NZ233502A (en) 1989-06-09 1991-11-26 Janssen Pharmaceutica Nv 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
PL181947B1 (en) 1994-01-24 2001-10-31 Janssen Pharmaceutica Nv Water-soluble azole-type antimycotic agents

Also Published As

Publication number Publication date
EE04155B1 (et) 2003-10-15
MY118844A (en) 2005-01-31
TW593312B (en) 2004-06-21
BRPI9811679B1 (pt) 2016-10-18
NO318328B1 (no) 2005-03-07
NO20000114D0 (no) 2000-01-10
EA200000116A1 (ru) 2000-08-28
AU749760B2 (en) 2002-07-04
DE69829082D1 (de) 2005-03-24
EP1068200A1 (en) 2001-01-17
DK1068200T3 (da) 2005-06-20
EP1068200B1 (en) 2005-02-16
PL338009A1 (en) 2000-09-25
ATE289303T1 (de) 2005-03-15
EA002828B1 (ru) 2002-10-31
DE69829082T2 (de) 2005-12-29
ID23783A (id) 2000-05-11
AR015130A1 (es) 2001-04-18
IL133919A (en) 2002-02-10
HUP0004459A3 (en) 2002-11-28
SK184199A3 (en) 2000-07-11
GEP20033054B (en) 2003-08-25
KR20010020576A (ko) 2001-03-15
AU8857698A (en) 1999-02-08
AP2000001730A0 (en) 2000-03-31
CA2295090C (en) 2009-09-08
UA71543C2 (uk) 2004-12-15
AP1379A (en) 2005-03-29
KR100540460B1 (ko) 2006-01-12
CA2295090A1 (en) 1999-01-21
WO1999002523A1 (en) 1999-01-21
BRPI9811679B8 (pt) 2021-05-25
IL133919A0 (en) 2001-04-30
HU225159B1 (en) 2006-07-28
HUP0004459A2 (hu) 2002-04-29
ZA986160B (en) 2000-01-10
CZ297453B6 (cs) 2006-12-13
SK285321B6 (sk) 2006-11-03
HRP20000007A2 (en) 2000-12-31
NZ501982A (en) 2000-10-27
BG64314B1 (bg) 2004-09-30
US6387906B1 (en) 2002-05-14
ES2238765T3 (es) 2005-09-01
CZ463799A3 (cs) 2000-04-12
BR9811679A (pt) 2000-09-19
NO20000114L (no) 2000-03-13
EE200000020A (et) 2000-10-16
TR200000154T2 (tr) 2000-06-21
BG103982A (en) 2000-08-31
HRP20000007B1 (en) 2008-12-31
PL193703B1 (pl) 2007-03-30
PT1068200E (pt) 2005-07-29
SI1068200T1 (es) 2005-08-31

Similar Documents

Publication Publication Date Title
AP1468A (en) Hiv inhibiting pyrimidine derivatives.
IL110328A0 (en) Derivatives of imidazo(1,2,a) pyrazin-4-one, their preparation and medicaments containing them
IL96770A0 (en) Pyridazinamines,their preparation and pharmaceutical compositions containing them
ES8802223A1 (es) Procedimiento para la preparacion de derivados de 2-oxi-4h-3, 1-benzoxazin-4-ona
FI951555A (fi) 5H,10H-imidatso[1,2-a]indeno[1,2-e]pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
IL127177A (en) ANTIPYSYCHOTIC 5-(1, 3, 4, 4a, 5, 9b-HEXAHYDRO-PYRIDO (3, 4-b) INDOL-2-YLALKYL) PYRIMIDIN-4-ONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MY113446A (en) 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives
HK1032404A1 (en) 2,4,4-Trisubstituted-1,3-dioxolane antifungals.
MY120046A (en) Angiogenesis inhibiting thiadiazolyl pyridazine derivatives.
ES8707718A1 (es) Procedimiento para la obtencion de 1-aril-5-alcoxiiminoalquilamino-pirazoles
IS4725A (is) Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa
ATE500231T1 (de) Hiv hemmende pyrimidin derivate
DE59604901D1 (de) Carbamoylcarbonsäureamide
ES8201979A1 (es) Procedimiento para la obtencion de derivados de bifeni- lil-azoliletano
ES8702380A1 (es) Procedimiento para preparar un derivado de (imina ciclica)- difenil-eter
MY118312A (en) Angiogenesis inhibiting 5- substituted- 1,2,4- thiadiazolyl derivatives
IL80524A (en) 5-amino-1-aryl-pyrazole derivatives,their preparation and herbicidal compositions containing them
JO1341B1 (en) Heterocyclic compounds
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
ES8604392A1 (es) Un procedimiento para preparar derivados de pirazinona.
AU653019B2 (en) New urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE PRIORITY APPLICATION NO. FROM 97202161.2 TO 97202181. ????????? 97202161.2 ??? 97202181?

CHRG Changes in the register

Free format text: CORRECTION OF THE PRIORITY APPLICATION NO. FROM 97202161.2 TO 97202181. ????????? 97202161.2 ??? 97202181?

PE Patent expired

Effective date: 20180706